The Worldwide Over-the-Counter (OTC) Drug Market.pdf
《The Worldwide Over-the-Counter (OTC) Drug Market.pdf》由会员分享,可在线阅读,更多相关《The Worldwide Over-the-Counter (OTC) Drug Market.pdf(197页珍藏版)》请在三一文库上搜索。
1、Worldwide Market for OTC Drugs Rures adquireret umbraculi, etiam tremulus matrimonii libere senesceret appMay 2010 Kalorama Information A division of MarketR 38 East 29th Street Sixth Floor New York, New York 10016 212.807 .2660 t 800.298.5603 t 212.807 .2676 f Copyright 2010 Kalorama Information R
2、eproduction without written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly prohibited WORLD OTC MARKETS A KALORAMA INFORMATION MARKET INTELLIGENCE REPORT World OTC Markets has been prepared by Kalorama Information. We serve business and industr
3、ial clients in the United States and abroad with a complete line of information services and research publications. Kalorama Information Market Intelligence Reports are specifically designed to aid the action-oriented executive by providing a thorough presentation of essential data and concise analy
4、sis. Author: Melissa Elder Publication Date: May 2010 38 East 29th Street New York, New York 10016 (800) 298-5699 Outside the U.S. (212) 807-2657 FAX: (212) 807-2676 www.KaloramaI E-MAIL: KLI1393075 COPYRIGHT 2010 Kalorama Information a division of MarketR, Inc. ii World OTC Markets 2010 Copyright
5、2010 Kalorama Information Reproduction without written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly prohibited TABLE OF CONTENTS CHAPTER ONE: EXECUTIVE SUMMARY1 Background .1 Scope and Methodology1 Size and Growth of the Market .3 Key Issues
6、and Trends Affecting Market.7 Leading Competitors7 CHAPTER TWO: INTRODUCTION.9 Background .9 Distribution and Safety Issues in the United States.10 Consumer Advertising/Promotion.11 World Health and Life Expectancy.12 Life Expectancy12 Birth Rates14 Tobacco Use .17 Obesity20 Declining Growth of the
7、World Population22 Prescription VS Over-the-Counter Industry24 Rx-to-OTC Switch Industry .27 Rx-to-OTC Switch Forecast in the United States.30 Economic Trends 33 Purchasing Power Trends.36 U.S. Healthcare Market 39 U.S. Healthcare Challenges41 Health Insurance Issues and Trends.42 Consumer Issues an
8、d Trends.43 U.S Consumers.44 Consumers around the World.45 Access to Professional Medical Services and the Link to Self-Medication45 Regulatory Environment46 Revisions to Pharmaceutical Affairs Law (PAL) in Japan.46 Russian Beneficiary Drug Provision Program47 A Third Class of Drugs in the United St
9、ates 47 CHAPTER THREE: OTC MARKETS IN ASIA-PACIFIC AND AFRICA.51 Table of Contents iii Copyright 2010 Kalorama Information Reproduction without written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly prohibited Overview.51 Demographics 51 OTC Pr
10、oduct Segments 59 Market Analysis.63 OTC Product Segment Market Analysis.68 Markets by Country.73 CHAPTER FOUR: OTC MARKETS IN EUROPE77 Overview.77 Demographics 77 OTC Product Segments 81 Market Analysis.84 OTC Product Segment Market Analysis.89 Markets by Country.94 CHAPTER FIVE: OTC MARKETS IN NOR
11、TH AMERICA98 Overview.98 Demographics 98 OTC Product Segments 101 Market Analysis.105 OTC Product Segment Market Analysis.110 Markets by Country.115 CHAPTER SIX: OTC MARKETS IN SOUTH AMERICA.119 Overview.119 Demographics 119 OTC Product Segments 122 Market Analysis.126 OTC Product Segment Market Ana
12、lysis.131 Markets by Country.136 CHAPTER SEVEN: SUMMARY OF WORLD OTC MARKETS139 Overview.139 OTC Product Segment Market Analysis.142 Markets by Country.147 iv World OTC Markets 2010 Copyright 2010 Kalorama Information Reproduction without written permission, in any media now in existence or hereafte
13、r developed, in whole or in any part, is strictly prohibited CHAPTER EIGHT: LEADING OTC MANUFACTURERS.151 Overview151 Competitor Analysis .151 Significant Mergers and Acquisitions.158 Sanofi-Aventis and Chattem Consumer .158 Schering-Plough and Merck however growth and new opportunities exist in dev
14、eloping nations. These bring new requirements and strategies into play for a variety of marketers. Some of these issues are discussed in this study. Issues and trends explored in this study include: Mergers and Acquisitions Distribution and Safety Issues Consumer Advertising and Promotion Demographi
15、cs World Health and Life Expectancy Trends Prescription vs. OTC Industry Rx-to-OTC Switch Industry Economic Trends Health Insurance Issues and Trends Consumer Issues and Trends Regulatory Environment Access to Medicine LEADING COMPETITORS The consumer healthcare market is highly fragmented with a ra
16、nge of large and small competitors. Although hundreds of companies compete in the world OTC 8 World OTC Markets 2010 Copyright 2010 Kalorama Information Reproduction without written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly prohibited drug
17、 market, a handful of companies secure leading positions. Many leading companies are taking advantage of new opportunities in developing regions, which is adding to the competitive landscape of the OTC market. In-depth profiles are included for the following companies: Bayer Consumer Health Boehring
18、er Ingelheim GlaxoSmithKline McNeil Consumer (Johnson amount of active ingredient per unit. Uses. Symptoms or diseases the product will treat or prevent. Warnings. When not to use the product; conditions that may require advice from a doctor before taking the product; possible interactions or side e
19、ffects; when to stop taking the product and when to contact a doctor; if you are pregnant or breastfeeding, seek guidance from a health care professional; keep product out of childrens reach. Inactive Ingredients. Substances such as colors or flavors. Purpose. Product action or category (such as ant
20、ihistamine, antacid, or cough suppressant. Directions. Specific age categories, how much to take, how to take, and how often and how long to take. Other Information. How to store the product properly and required information about certain ingredients (such as the amount of calcium, potassium, or sod
21、ium the product contains) Chapter Two: Introduction 11 Copyright 2010 Kalorama Information Reproduction without written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly prohibited CONSUMER ADVERTISING/PROMOTION The U.S. Federal Trade Commission (
22、FTC) regulates the advertising of OTC products in the U.S. while the FDA regulates labeling. The FTC pays significant attention to the way an OTC product is marketed. Claims must be truthful and must not deceive the consumer. They must be backed by substantial scientific evidence. In most countries
23、it is typical for a consumer to review product labeling when making a decision concerning the purchase of a health treatment. Therefore, marketing of OTC medicines is often viewed as a tool to educate consumers about available treatments. Others find the counseling of a pharmacy worker adequate to d
24、irect them to the best treatment. The effects of Direct-to-Consumer Advertising (DTCA) is a topic of interest in both prescription and non-prescription pharmaceuticals. For prescription drugs, DTCA is not allowed worldwide with the exception of the U.S., New Zealand, Bangladesh and Korea. In most co
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- The Worldwide Over-the-Counter OTC Drug Market Over Counter OTC
链接地址:https://www.31doc.com/p-3800891.html